首页 / 产品中心 / 产品类型 / 抗体产品 / 特色抗体推荐

DNA Repair in Chromatin Context

Chromatinized DNA Damage

Eukaryotic DNA is highly compacted and organized in nuclear space (1). To achieve this three-dimensional organization, DNA is wrapped around histone proteins in the form of chromatin (2, 3). Chromatin fibers with varying degrees of compaction and distinct types of chemical modification ensure proper gene expression and structural integrity of the genome (1). The integrity of chromatinized DNA is highly susceptible to both exogenous and endogenous sources of damage. Exogenous, or environmental damage can be produced by ultraviolet (UV) light from sunlight and ionizing radiation (IR, from, e.g., cosmic radiation and medical treatments employing X-rays or radiotherapy) as well as genotoxic carcinogens including topoisomerase inhibitors camptothecin (CPT) and etoposide, which inhibit topoisomerase I or II, respectively (4). The most frequent cell-intrinsic sources of genotoxic stress include free oxygen radicals as a result of increased cellular respiration, collapsed DNA replication forks as a consequence of abnormal cell division and variable joining of V, D and J gene segments or class switch recombination in vertebrate lymphocytes (5).

DNA Damage Related Antibodies

ABclonal货号 产品名称 抗体来源 产品应用 应用物种

DNA Repair Pathways

To counteract DNA damage, cells have evolved complex and elaborate mechanisms to repair different types of DNA lesions. Hundreds of repair genes have been identified, which mainly participate in five distinct but functionally interconnected pathways: base excision repair (BER), nucleotide excision repair (NER), mismatch repair (MMR), non-homologous end joining (NHEJ) and homologous recombination (HR).

BER

Single damaged bases resulting from chemically modifications can affect the ability of the bases to form hydrogen-bonds and lead to incorrect base-pairing. These mutations could be induced by IR, topoisomerase I poisons or some antimetabolites, and are largely repaired by BER (Figure 1A). The key components of the BER pathway are glycosylases, endonucleases, DNA polymerases and DNA ligases, with poly(ADP-ribose) polymerase 1(PARP1) and PARP2 facilitating the process (6). Damaged bases are first removed by glycosylases and endonucleases to form abasic sites and generate a 'nick' or a single-strand break, which can then be processed by either short-patch BER (where a single nucleotide is replaced) or long-patch BER (where 2-10 new nucleotides are synthesized) (7).

Figure 1. BER and NER. (A) In the first step of BER, the deaminated bases are removed by specific glycosylases. The resulting apurinic or apyrimidinic (AP) site is further hydrolysed by an AP endonuclease. The nick in the DNA is then repaired by DNA polymerases and DNA ligases. (B) After recognizing damaged DNA, NER is executed through dual incision by Transcription Factor II H (TFIIH), gap filling by DNA polymerases and ligation dependent on DNA ligase I and Flap endonuclease 1 or the Ligase-III-XRCC1 complex to seal the nicks to complete NER.

NER

NER acts to remove helix-distorting adducts on DNA, for example, those caused by ultraviolet (UV) radiation and tobacco smoke. The xeroderma pigmentosum (XP) proteins and Cockayne syndrome associated proteins have crucial roles in this pathway (7). Eukaryotic NER can be divided into two subpathways: global genomic NER (GG-NER) and transcription coupled NER (TC-NER). For each subpathway, two distinct sets of proteins are involved in recognizing DNA damage (7). After that, the two subpathways converge for the steps of dual incision by Transcription factor II H (TFIIH), gap filling through DNA polymerases and ligation dependent on DNA ligase I and Flap endonuclease 1 or the Ligase-III-XRCC1 complex to seal the nicks to complete NER (Figure 1B).

MMR

MMR is a system for recognizing and repairing the daughter-strand specific replication errors that cause incorporation of the wrong nucleotide (a mismatch) and nucleotide insertions or deletions. The mispaired or fraudulent nucleotide is recognized by MSH2-MSH6 heterodimers, whereas deletions and insertions are recognized by MSH2-MSH3 heterodimers (6, 8). Besides specific MMR factors such as MLH1MLH3 heterodimers required to process the downstream signaling, components of other DNA repair pathways including endonuclease 1, replication protein A (RPA), proliferating cell nuclear antigen (PCNA) and flap endonuclease 1 (FEN1) have also been implicated in excision and resynthesis past the lesion. Defective MMR increases mutation rates up to 1,000-fold, and results in microsatellite instability (MSI) thus cancer development (9).

NHEJ and HR

DSBs are among the most difficult lesions to repair and are profoundly cytotoxic, as the failure to repair DSBs can cause cell death, and their aberrant repair can lead to gross chromosomal changes. DSB repair generally occurs through one of two major pathways: nonhomologous end joining (NHEJ), which is by nature error-prone and ligates broken DNA with minimal end processing, or homologous recombination (HR), which restores the original DNA sequence using unperturbed template DNA, generally the sister chromatid (7, 9) (Figure 2). NHEJ is active in all phases of the cell cycle, predominating in G0 phase and G1 phase of the cell cycle, and it is considered to be responsible for the rapid repair of up to 85% of IR-induced DSBs. Although HR is generally limited to the S and G2 phase of the cell cycle and repairs only a minor proportion of DSBs, it may be the most crucial as it is high fidelity in dealing with stalled and collapsed replication forks, as well as single-ended DSBs, and also the processing of interstrand crosslinks (ICLs) in cooperation with the NER and Fanconi anaemia pathways (6). In HR, the broken DNA ends of a DSB are resected to allow invasion of the single strands into the sister chromatid, which functions as a spatially accessible template for accurate resynthesis of the damaged DNA (8).

DNA Damage Response and DNA Repair

Inappropriate repair of damaged DNA has deleterious effects not only on DNA lesion itself but other DNA transactions including DNA replication and gene transcription, and ultimately results in mutations and chromosomal aberrations (10). Thereby, the ability of cells to maintain genome integrity through orchestrating DNA damage response (DDR) temporally and spatially is vital for cellular homeostasis. The DDR is primarily mediated by proteins of the phosphatidylinositol 3-kinase-like protein kinase (PIKKs) family-ATM, ATR, and DNA-PK and by members of the PARP family-PARP1 and PARP2 (11). Through sensing/recognizing particular DNA lesions, these factors activate the DDR and set a choreographed response in motion to protect the cell and ameliorate the threat to the organism (4). Following or in concert with DDR activation, DNA repair is carried out by a plethora of enzymatic activities that chemically or physically modify repair proteins and chromatin structures in a reversible manner (Figure 2). These enzymes include but are not limited to nucleases, helicases, polymerases, topoisomerases, recombinases, ligases, glycosylases, methyltransferases, demethylases, ubiquitin ligases, deubiquitinases, kinases, and phosphatases (1, 12-16). In addition to these versatile enzymes, many DDR or repair processes involve scaffold proteins that lack inherent catalytic or DNA-binding functions, but function to recognize particular chemical modification via distinct reader domains or facilitate the association of functional subunits into multiprotein complexes. To timely respond to the damage stimuli and faithfully restore the breaks, these repair tools together with their modulators must be precisely regulated both temporally and spatially in the context of the surrounding chromatin, otherwise each in its own right can wreak havoc on the integrity of DNA as well as break proximal or distal chromatin configuration (17-19). Although a lot of work has been done to investigate cellular mechanisms that regulate the recruitment of DNA repair factors to sites of DNA damage and coordinate the choice of the pathways to employ for efficient DNA repair, the underlying mechanisms and implications of DNA repair in chromatin context are only beginning to be understood.

Figure 2. DSBs Repair and DDR. DSBs activate a complex cellular DNA-damage response (DDR) involving a signal transduction pathway that senses the breaks and sets in motion a highly orchestrated series of events. The DDR is generally initiated by the rapid accumulation of the MRN (MRE11-RAD50-NBS1) complex at the break sites, which is in turn crucial for the recruitment and activation of the central DDR signaling kinase Ataxia Telangiectasia Mutated (ATM). ATM then phosphorylates a conserved residue of the histone variant H2AX (S139 in humans, referred to as γ-H2AX), providing a high-affinity binding site for MDC1, which in turn orchestrates the recruitment of a variety of functionally distinct downstream DNA break-associated repair factors including ubiquitin ligases RNF8 and RNF168. Accumulating evidence suggests that the assembly of such repair foci is regulated both temporally and spatially in the context of the surrounding chromatin. Consistent with this notion, a vast number of enzymatic complexes that chemically or physically modify chromatin structures in a reversible manner have been linked to DSB repair such as Nucleosome Remodeling Deacetylase complex (NuRD) and polycomb repressive complex (PRC1/2). DSB repair generally occurs through (NHEJ) and HR: NHEJ repairs DSBs in all phases of the cell cycle, while HR is dependent on the presence of a homologous DNA template and, thus, generally limited to S phase and G2.

Defects in the maintenance of genome stability underlie a number of developmental disorders and human diseases including developmental defects, neurodegenerative diseases and cancers, which highlights the critical importance of an efficient DDR and repair program for cell and organism viability (11, 20-22). Classically, defects in the DDR and repair pathways have been taken advantage to exploit therapeutically in the treatment of cancer with radiation therapies or genotoxic chemotherapies. More recently, protein components that are amenable to modulation by small molecules among the DDR or DNA repair systems, have been identified as promising targets in cancer therapeutics.

References

  • 1、Oberdoerffer P, Sinclair DA. The role of nuclear architecture in genomic instability and ageing. Nat Rev Mol Cell Biol. 2007;8(9):692-702.
  • 2、Varala K, Li Y, Marshall-Colon A, Para A, Coruzzi GM. "Hit-and-Run" leaves its mark: catalyst transcription factors and chromatin modification. BioEssays : news and reviews in molecular, cellular and developmental biology. 2015;37(8):851-6.
  • 3、Klose RJ, Zhang Y. Regulation of histone methylation by demethylimination and demethylation. Nat Rev Mol Cell Biol. 2007;8(4):307-18.
  • 4、Chapman JR, Taylor MR, Boulton SJ. Playing the end game: DNA double-strand break repair pathway choice. Molecular cell. 2012;47(4):497-510.
  • 5、Shi L, Oberdoerffer P. Chromatin dynamics in DNA double-strand break repair. Biochimica et biophysica acta. 2012;1819(7):811-9.
  • 6、Curtin NJ. DNA repair dysregulation from cancer driver to therapeutic target. Nature reviews Cancer. 2012;12(12):801-17.
  • 7、Jeggo PA, Pearl LH, Carr AM. DNA repair, genome stability and cancer: a historical perspective. Nature reviews Cancer. 2016;16(1):35-42.
  • 8、Helleday T, Petermann E, Lundin C, Hodgson B, Sharma RA. DNA repair pathways as targets for cancer therapy. Nature reviews Cancer. 2008;8(3):193-204.
  • 9、Pearl LH, Schierz AC, Ward SE, Al-Lazikani B, Pearl FM. Therapeutic opportunities within the DNA damage response. Nature reviews Cancer. 2015;15(3):166-80.
  • 10、Aguilera A, Gomez-Gonzalez B. Genome instability: a mechanistic view of its causes and consequences. Nat Rev Genet. 2008;9(3):204-17.
  • 11、Bonner WM, Redon CE, Dickey JS, Nakamura AJ, Sedelnikova OA, Solier S, et al. GammaH2AX and cancer. Nat Rev Cancer. 2008;8(12):957-67.
  • 12、Misteli T, Soutoglou E. The emerging role of nuclear architecture in DNA repair and genome maintenance. Nat Rev Mol Cell Biol. 2009;10(4):243-54.
  • 13、Vidanes GM, Bonilla CY, Toczyski DP. Complicated tails: histone modifications and the DNA damage response. Cell. 2005;121(7):973-6.
  • 14、Polo SE, Almouzni G. Chromatin dynamics after DNA damage: The legacy of the access-repair-restore model. DNA repair. 2015;36:114-21.
  • 15、Clouaire T, Legube G. DNA double strand break repair pathway choice: a chromatin based decision? Nucleus. 2015;6(2):107-13.
  • 16、House NC, Koch MR, Freudenreich CH. Chromatin modifications and DNA repair: beyond double-strand breaks. Frontiers in genetics. 2014;5:296.
  • 17、Groth A, Rocha W, Verreault A, Almouzni G. Chromatin challenges during DNA replication and repair. Cell. 2007;128(4):721-33.
  • 18、Khurana S, Kruhlak MJ, Kim J, Tran AD, Liu J, Nyswaner K, et al. A macrohistone variant links dynamic chromatin compaction to BRCA1-dependent genome maintenance. Cell reports. 2014;8(4):1049-62.
  • 19、Li ML, Yuan G, Greenberg RA. Chromatin yo-yo: expansion and condensation during DNA repair. Trends in cell biology. 2014;24(11):616-8.
  • 20、Li X, Liu L, Yang S, Song N, Zhou X, Gao J, et al. Histone demethylase KDM5B is a key regulator of genome stability. Proceedings of the National Academy of Sciences of the United States of America. 2014;111(19):7096-101.
  • 21、Wang Q, Ma S, Song N, Li X, Liu L, Yang S, et al. Stabilization of histone demethylase PHF8 by USP7 promotes breast carcinogenesis. The Journal of clinical investigation. 2016;126(6):2205-20.
  • 22、Pan L, Penney J, Tsai LH. Chromatin regulation of DNA damage repair and genome integrity in the central nervous system. Journal of molecular biology. 2014;426(20):3376-88.
查看更多>>